Jae-ChiangWongDO

PubMed

• Assessing the therapeutic role of trehalose and hyaluronic acid: implications for patient care.
  Ahmed Gawash, Alexa Simonetti, David F Lo, Don D Shamilov, Aman Kumar
  International Ophthalmology. 2024-10-01
• 1 citations
  Glaucoma Surgical Outcomes in Patients with a History of Scleritis.
  Jae-Chiang Wong, Esika Savsani, Raziyeh Mahmoudzadeh, Mirataollah Salabati, Reza Razeghinejad
  Ocular Immunology and Inflammation. 2024-08-01
• Long-Term Surgical Outcomes of Glaucoma Drainage Implants in Eyes with Preoperative Intraocular Pressure Less than 19 mmHg.
  Shahin Hallaj, Jae-Chiang Wong, Lauren E Hock, Natasha Nayak Kolomeyer, Aakriti G Shukla
  Journal of Ophthalmology. 2024-01-01

Journal Articles

• The Long-Term Clinical Outcomes of Latanoprostene Bunod 0.024% in Glaucoma Treatment at a Tertiary Glaucoma Center  
  Jae-Chiang Wong, Rebecca F. Neustein, Melih Ustaoglu, Eric Shiuey, Nikki Mehran, Marlene R. Moster, Reza Razeghinejad, L. Jay Katz, Jonathan Myers & Daniel Lee, Expert Review of Ophthalmology, 10/30/2023
• Clinical outcomes of collagen matrix as adjuvant to open bleb revision with mitomycin C following failed trabeculectomy  
  Jae-Chiang Wong, Jordan Safran, Shahin Hallaj, Eric Shiuey, Connie Wu, Daniel Lee, Expert Review of Ophthalmology, 9/25/2023
• Glaucoma-Related Malpractice Litigation in the United States: A Review of the WestLaw Database  
  Jae-Chiang Wong BS, Nikki A. Mehran MD, Mark Andriola JD, Daniel Lee MD, Jonathan S. Myers MD, Natasha Nayak Kolomeyer MD, Journal of Patient Safety and Risk Management, 11/16/2022
• Contrasting feeding habits of post-larval and adult Astyanax cavefish  
  Luis Espinasa, Natalie Bonaroti, Jae Wong, Karen Pottin, Eric Queinnec, Sylvie Rétaux, Subterranean Biology, 1/6/2017
• Join now to see all

Abstracts/Posters

• Non-Arteritic Anterior Ischemic Optic Neuropathy in the Setting of Newly Diagnosed Inflammatory Bowel Disease
  Wong JC, Goyal A, Elefant D, North American Neuro-Ophthalmology Society, Orlando, FL, 3/12/2023
• Lost to Follow Up and Changes in Glaucoma Follow-Up Care in the Peri-COVID Era
  Wong J, Mcgarrey M, Zhang Q, Sharpe J, Hallaj S, Lee D, Razeghinejad R, Shukla AG, Myers JS, Kolomeyer NN, American Academy of Opthalmology, Chicago, IL, 10/2022
• Effect of Early Postoperative Aqueous Suppression Therapy on Surgical Outcomes of Valved Tube Shunts in Refractory Glaucoma
  Shalaby WS, Wong J, Zhang T, Lam SS, Dale E, Pro MJ, Shukla AG, Lee D, Myers JS, Razeghinejad R, Moster MR, American Academy of Ophthalmology, Chicago, IL, 10/2022
• Artificial Intelligence Assisted Prediction of Selective Laser Trabeculoplasty Failure in Glaucoma Patients
  Hallaj S, Wong J, Razeghinejad R, Shukla AG, Kolomeyer NN, Myers JS, Lee D, American Academy of Ophthalmology, Chicago, IL, 10/2022
• 10-Year Clinical Outcomes of Tube Shunt Surgery for Glaucomatous Eyes
  Lamrani R, Wong J, Lee D, Myers JS, European Glaucoma Society, Athens, Greece, 6/2022
• Long-term Surgical Outcomes of Trabeculectomy in Eyes with Low Baseline Intraocular Pressure
  Patel C, Wong J, Hallaj S, Razeghinejad R, Shukla AG, Kolomeyer NN, Myers JS, Lee D, Association for Research in Vision and Ophthalmology, Denver, CO, 5/2022
• One-year Outcomes of Trabecular Meshwork Microstent Placement in Eyes with Severe Glaucoma
  Wong J, Zhang T, Haghshenas C, Hallaj S, Razeghinejad R, Shukla AG, Myers JS, Lee D, Association for Research in Vision and Ophthalmology, Denver, CO, 5/2022
• Long-term Outcomes of Glaucoma Drainage Implants in Patients with Baseline IOP Less Than 19 mmHg
  Hallaj S, Wong J, Razeghinejad R, Shukla AG, Kolomeyer NN, Myers JS, Lee D, Association for Research in Vision and Ophthalmology, Denver, CO, 5/2022
• Glaucoma Surgical Outcomes in Patients with a History of Scleritis or Scleral Thinning
  Wong J, Savsani E, Mahmoudzadeh R, Salabati A, Dunn JP, Kolomeyer NN, American Society for Cataract and Refractive Surgery, Washington D.C., 4/2022
• The Application of Collagen Matrix to Reverse Hypotony Following Trabeculectomy with Mitomycin C
  Wong J, Safran J, Lee D, American Society of Cataract and Refractive Surgery, Washington D.C., 4/2022
• The Long-Term Efficacy and Safety Profile of Latanoprostene Bunod 0.024% in Glaucoma Treatment: The Wills Experience
  Neustein RF, Wong J, Ustaoglu M, Shiuey E, Mehran N, Moster MR, Razeghinejad R, Katz J, Myers JS, Lee D, American Glaucoma Society, Nashville, TN, 3/2022
• Join now to see all